Welcome to Crene Biotechnology!

+86-576-88205808

Catalog No CAS NO Product name
CR2913
1239875-86-5
SGI-7079
SGI-7079 is a potent and selective Axl inhibitor with potential anticancer activity. SGI-7079 effectively inhibited Axl activation..
CR2517
1345847-93-9
Altiratinib DCC2701
Altiratinib, also known as DCC-270, DP-5164, is an oral, selective and highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinase..
CR2394
1125780-41-7
SKLB610
SKLB610 is a VEGFR inhibitor that potently suppresses human tumor angiogenesis. SKLB610 inhibited angiogenesis-related tyrosine ki..
CR2214
811803-05-1
YN-968D1 Apatinib
Apatinib, also known as Rivoceranib, is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential a..
CR2169
1058137-23-7
E-3810 Lucitanib
Lucitanib , also known as E-3810 and AL3810, is a novel dual inhibitor targeting human vascular endothelial growth factor receptor..
CS0127
1433953-83-3
SAR-131675
SAR131675 is a potent and selective VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylati..
CR1937
204005-46-9
SU5416 Semaxanib
Semaxanib, also known as SU5416, is a quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits A..
CR1633
215543-92-3
SU5402
SU5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) ..
CR1474
849217-64-7
Foretinib GSK1363089
Foretinib, also known as XL880 and GSK1363089, is an orally bioavailable small molecule with potential antineoplastic activity. ME..
CR1468
649735-46-6
BMS-540215 Brivanib
Brivanib is the hydrolyzed form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor..
首页上一页当前第1/4页共31条记录每页10条123下一页尾页
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021Taizhou Crene Biotechnology Co., Ltd.

Address:Economic Developed Zone of Taizhou Zhejiang China.